(Q34461434)

2 August 2017

1 reference

title

Antiepileptic drugs and neuroprotection: current status and future roles (English)

1 reference

2 August 2017

L James Willmore

1

1 reference

2 August 2017

18 October 2005

1 reference

2 August 2017

1 reference

2 August 2017

7 Suppl 3

1 reference

2 August 2017

S25-8

1 reference

Post-traumatic epilepsy: cellular mechanisms and implications for treatment

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Valproate therapy for prevention of posttraumatic seizures: a randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Effect of phenytoin and corticosteroids on seizures and lipid peroxidation in experimental posttraumatic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Disease modification in partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

7 January 2021

Neuroprotective therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Antiepileptic drugs to prevent neural degeneration associated with epilepsy: assessing the prospects for neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Glutamate neurotoxicity and diseases of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Glutamate excess and free radical formation during and following kainic acid-induced status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Glutamate neurotoxicity in cortical cell culture is calcium dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischaemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Electroencephalographic and histological characteristics of a model of limbic status epilepticus permitting direct control over seizure duration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Zonisamide reduces the increase in 8-hydroxy-2'-deoxyguanosine levels formed during iron-induced epileptogenesis in the brains of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Lamotrigine attenuates cortical glutamate release during global cerebral ischemia in pigs on cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Lamotrigine improves cerebral outcome after hypothermic circulatory arrest: a study in a chronic porcine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Effect of a neuronal sodium channel blocker on magnetic resonance derived indices of brain water content during global cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Neuroprotective effects of lamotrigine enhanced by flunarizine in gerbil global ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Maturational aspects of epilepsy mechanisms and consequences for the immature brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Zonisamide as a neuroprotective agent in an adult gerbil model of global forebrain ischemia: a histological, in vivo microdialysis and behavioral study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Protective effect of zonisamide, an antiepileptic drug, against transient focal cerebral ischemia with middle cerebral artery occlusion-reperfusion in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsive effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

The anticonvulsant zonisamide scavenges free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Neuroimmunophilins: novel neuroprotective and neuroregenerative targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Caspases as treatment targets in stroke and neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Antioxidant therapy in acute central nervous system injury: current state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

Effect of [dl]-alpha-tocopherol on FeCl2-induced lipid peroxidation in rat amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.006

10.1016/J.YEBEH.2005.08.006

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

16239127